KRAS and neoplasm: In this regard, we genetically demonstrate that the inability of KRASC118S to restore tumor growth of HRASG12V-transformed human cells upon knocking down endogenous KRAS could be restored, in large part, by introducing an activating mutation into the KRASC118S transgene.